1. Home
  2. GCL vs NYXH Comparison

GCL vs NYXH Comparison

Compare GCL & NYXH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GCL
  • NYXH
  • Stock Information
  • Founded
  • GCL 2011
  • NYXH 2009
  • Country
  • GCL Singapore
  • NYXH Belgium
  • Employees
  • GCL N/A
  • NYXH N/A
  • Industry
  • GCL
  • NYXH Medical/Dental Instruments
  • Sector
  • GCL
  • NYXH Health Care
  • Exchange
  • GCL NYSE
  • NYXH Nasdaq
  • Market Cap
  • GCL 314.4M
  • NYXH 290.9M
  • IPO Year
  • GCL N/A
  • NYXH 2021
  • Fundamental
  • Price
  • GCL $3.60
  • NYXH $8.12
  • Analyst Decision
  • GCL
  • NYXH Strong Buy
  • Analyst Count
  • GCL 0
  • NYXH 4
  • Target Price
  • GCL N/A
  • NYXH $14.50
  • AVG Volume (30 Days)
  • GCL 97.8K
  • NYXH 38.5K
  • Earning Date
  • GCL 01-01-0001
  • NYXH 08-05-2025
  • Dividend Yield
  • GCL N/A
  • NYXH N/A
  • EPS Growth
  • GCL N/A
  • NYXH N/A
  • EPS
  • GCL N/A
  • NYXH N/A
  • Revenue
  • GCL $112,351,837.00
  • NYXH $4,716,818.00
  • Revenue This Year
  • GCL N/A
  • NYXH $323.07
  • Revenue Next Year
  • GCL N/A
  • NYXH $204.30
  • P/E Ratio
  • GCL N/A
  • NYXH N/A
  • Revenue Growth
  • GCL 25.23
  • NYXH N/A
  • 52 Week Low
  • GCL $1.76
  • NYXH $5.55
  • 52 Week High
  • GCL $9.89
  • NYXH $11.87
  • Technical
  • Relative Strength Index (RSI)
  • GCL N/A
  • NYXH 67.67
  • Support Level
  • GCL N/A
  • NYXH $7.40
  • Resistance Level
  • GCL N/A
  • NYXH $8.03
  • Average True Range (ATR)
  • GCL 0.00
  • NYXH 0.26
  • MACD
  • GCL 0.00
  • NYXH 0.05
  • Stochastic Oscillator
  • GCL 0.00
  • NYXH 100.00

About GCL GCL GLOBAL HOLDINGS LTD

GCL Global Holdings Ltd is a provider of games and entertainment content based in Asia. The company unites people through games and entertainment experiences, enabling creators to deliver engaging content and fun gameplay experiences to the gaming communities across the globe, with a strategic focus on the rapidly expanding Asian gaming market. Its mission is to bridge cultures and audiences by introducing Asian-developed IP to a multinational audience across consoles, PCs and streaming platforms.

About NYXH Nyxoah SA

Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The company's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.

Share on Social Networks: